Prevalence of genital Chlamydia trachomatis among women of reproductive age attending outpatient clinic at Kisumu County Referral Hospital, Kenya, 2021
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Background. Chlamydia trachomatis is a common a sexually transmitted infections (STI). Asymptomatic Chlamydia is undetectable because it is asymptomatic. In Kenyan women ages 18 to 49, the disease is poorly understood.
Methods. This cross-sectional study was conducted at Kisumu County Referral Hospital, Kenya. 385 women consented and completed the electronic questionnaire. The women then provided vaginal swab samples which were tested for Chlamydia trachomatis using Chlamydia rapid diagnostic test kit.
Results. A total of 29 (7.5%) patients tested positive and were given medication. 65.2% of 385 participants were 18-25, with 5.7% prevalence. Women preferred self vaginal swab collection over health worker collection (0.3%). Multiple sexual partners, coinfection with other STIs, and upper tract infections are linked to genital Chlamydia. 92% of participants didn’t know Chlamydia’s effects.
Conclusions. The study’s prevalence of genital Chlamydia trachomatis was within previous estimates. Populations and screening methods vary. Patient and community education about genital Chlamydia infection is needed. Multiple sexual partners, marital status, education, and STI history are risk factors. Most women preferred self vaginal swab collection.
2. Tsevat DG, Wiesenfeld HC, Parks C, Peipert JF. Sexually transmitted diseases and infertility. Am J Obstet Gynecol [Internet]. 2017;216(1):1–9. Available from: http://dx.doi.org/10.1016/j.ajog.2016.08.008
3. Haugland S, Thune T, Fosse B, Wentzel-Larsen T, Hjelmevoll SO, Myrmel H. Comparing urine samples and cervical swabs for Chlamydia testing in a female population by means of Strand Displacement Assay (SDA). BMC Womens Health. 2010;10:1–6.
4. G B. The performance of non-NAAT point-of-care (POC) tests and rapid NAAT tests for chlamydia and gonorrhoea infections. An assessment of currently available assays. Sex Transm Infect. 2015;118.
5. Sykes JE. Chlamydial Infections. Feline Med Ther Third Ed. 2008;651–8.
6. Kohli R, Konya WP, Obura T, Stones W, Revathi G. Prevalence of genital chlamydia infection in urban women of reproductive age, Nairobi, Kenya. BMC Res Notes. 2013;6(1):2–6.
7. Kerubo E, Laserson KF, Otecko N, Odhiambo C, Mason L, Nyothach E, et al. Prevalence of reproductive tract infections and the predictive value of girls’ symptom-based reporting: findings from a cross-sectional survey in rural western Kenya. Sex Transm Infect. 2016;92(4):251–6.
8. Maina AN, Kimani J, Anzala O. Prevalence and risk factors of three curable sexually transmitted infections among women in Nairobi, Kenya. BMC Res Notes. 2016;9(1):1–5.
9. Al-assadi AF, Yassin Z, Abood HS. Obstetrics and Gynecological Surgery. 2020;1(2):1–6.
10. Opoku B, Sarkodie Y. Prevalence of genital Chlamydia and Gonococcal infections in at risk women in the Kumasi metropolis, Ghana. Ghana Med J. 2011;44(1):2–5.
11. Torrone E, Papp J, Weinstock H, Centers for Disease Control and Prevention (CDC). Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012. MMWR Morb Mortal Wkly Rep [Internet]. 2014;63(38):834–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25254560%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4584673
Copyright (c) 2022 Martha Nyakambi, Anthony Waruru, Adesina Oladokun
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.